U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology services. It operates through the following business areas: In vitro diagnostics services, Information Technology (IT) solutions, and Personal health management services. In vitro diagnostics business area offers general diagnostic tests, molecular diagnostic tests, and research authorization clinical services. The IT solution business area offers medical practitioner-centered health examination, specialized medical examination and diagnostic equipment, and electronic medical record interworking solutions. The Personal health management services business area offers breast milk analysis service and telomere length measurement service. The company was founded on January 2, 2009 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company